When it comes to artificial intelligence in the supplement industry, not all consumers are equally skeptical. Recent research reveals a surprising divide: supplement users demonstrate significantly higher trust in AI technology than non-users, but they also demand stronger safeguards and transparency around its use.

The Trust Gap Between Supplement Users and Non-Users

Research conducted by a UK-based public relations firm in October 2024 surveyed over 1,000 consumers in the United States and United Kingdom, revealing striking differences in AI perception. According to findings reported by NutraIngredients-USA, 64% of supplement users view AI as a positive development for humanity, compared to just 40% of non-supplement users.

This trust gap widens when considering AI's role in product development. While 55% of supplement users feel positively about AI in the food and beverage industry, only 30% of non-users share that optimism. The research suggests supplement consumers may be more inclined to embrace scientific and technological innovation when it promises to enhance wellbeing or provide performance advantages.

Perhaps most telling, 62% of supplement users would trust AI to analyze their genetic data and make personalized nutrition recommendations, compared to only 33% of non-users. Similarly, 59% of supplement users believe AI could make dietary decisions in their best interests, while just 28% of non-users feel comfortable with that proposition.

Higher Trust Meets Higher Expectations for Transparency

The research reveals a critical nuance that businesses must understand: supplement consumers' greater acceptance of AI comes paired with stronger demands for transparency and accountability. Among supplement users, 87% believe products developed with AI assistance should carry label declarations disclosing that fact, compared to 79% of non-users who want similar transparency.

Additionally, 68% of supplement users say AI-developed products should not be described as "natural," with 62% of non-users taking the same position. This presents an interesting compliance challenge for businesses using quality management systems like Q-Trust to manage product development and labeling accuracy.

For nutraceutical companies, this data suggests an opportunity: consumers who already use supplements are primed to accept AI-enhanced products and services, but only if businesses provide clear, honest communication about how the technology is deployed. Companies that hide AI involvement risk losing credibility with a consumer base that values both innovation and transparency.

The Broader Context of Growing AI Anxiety

While supplement users show relative comfort with AI, broader consumer sentiment has shifted dramatically. According to Pew Research Center data, American consumers have grown increasingly wary of artificial intelligence over recent years. In 2021, 37% of respondents said they were "more concerned than excited" about AI, while 18% were "more excited than concerned." By 2023, those numbers had shifted to 52% concerned and just 10% excited.

This growing anxiety extends specifically to healthcare contexts. A 2022 Pew survey found 60% of respondents would feel uncomfortable if their healthcare provider used AI when treating patients. For supplement businesses operating in the health and wellness space, this presents both challenge and opportunity.

Compliance Implications for AI-Enhanced Product Development

The research findings have direct implications for how supplement businesses should approach AI integration and compliance management. Companies using AI for product formulation, personalized recommendations, or quality control processes need clear policies around disclosure and transparency.

Businesses leveraging compliance monitoring should consider how AI tools factor into their transparency commitments. If AI analyzes COAs, identifies quality issues, or recommends formulation adjustments, should that be disclosed to consumers? According to this research, the majority of your target audience believes it should be.

Similarly, companies deploying AI chatbots for customer service or personalized supplement recommendations need to ensure those tools operate within FDA guidelines for supplement marketing. AI systems must avoid making prohibited disease claims, provide appropriate disclaimers, and maintain the same compliance standards as human representatives.

Building Trust Through Transparent AI Integration

The research suggests supplement businesses have a receptive audience for AI innovation, but only if they prioritize transparency. Companies should consider developing clear AI disclosure policies that explain how the technology is used in product development, quality control, personalization services, and customer interactions.

This transparency extends beyond label declarations. Businesses might proactively communicate how AI enhances quality management, improves consistency, identifies contamination risks, or personalizes recommendations while maintaining human oversight of critical decisions. Quality management systems that integrate AI capabilities while maintaining comprehensive audit trails position companies to demonstrate both innovation and accountability.

Turn AI Innovation Into Competitive Advantage With Transparent Compliance

As AI becomes increasingly integral to supplement product development and customer service, transparent compliance management separates industry leaders from companies that will face consumer backlash or regulatory scrutiny. Q-Trust helps nutraceutical businesses integrate advanced technology while maintaining the transparency and accountability that today's informed consumers demand.

Ready to build consumer trust through transparent, compliant AI integration? Contact Qredible today to discover how Q-Trust supports innovation while ensuring your AI-enhanced processes maintain the highest standards of regulatory compliance and consumer transparency.

Source: Schultz, Hank. "Supplement users more trusting of AI, survey finds." NutraIngredients-USA, January 30, 2025.